Trial Profile
Objective efficacy of mirabegron on storage and voiding function in patients with over-active bladder that are unresponsive to antimuscarinic treatment: a urodynamic study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2015
Price :
$35
*
At a glance
- Drugs Mirabegron (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 09 Oct 2015 Results (n=60) presented at the 45th Annual Meeting of the International Continence Society
- 11 Sep 2015 New trial record